Low-dose “metronomic chemotherapy” with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit

We report the case of a 34-year-old woman affected by breast cancer that had metastasized to the bone. She had been treated with oral cyclophosphamide and methotrexate (metronomic chemotherapy) and achieved 3.5 years of clinical remission. To our knowledge, this is the first description of such a pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Masci, G, Losurdo, A, Gandini, C, Garassino, I, di Tommaso, L, Torrisi, R, Zuradelli, M, Santoro, A
Formato: Artigo
Lenguaje:Inglês
Publicado: Cancer Intelligence 2012
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3484813/
https://ncbi.nlm.nih.gov/pubmed/23130087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2012.275
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares